Replies to post #233960 on Biotech Values

[DewDiligence]

CERE begins trading today—consequent to a SPAC reverse-merger announced in July (#msg-157265361):

https://www.globenewswire.com/news-release/2020/10/28/2115803/0/en/Cerevel-Therapeutics-Debuts-as-Publicly-Traded-Neuroscience-Company.html